Identification ofcagATyrosine Phosphorylation DNA Motifs inHelicobacter pyloriIsolates from Peptic Ulcer Patients by Novel PCR-Restriction Fragment Length Polymorphism and Real-Time Fluorescence PCR Assays
- 1 July 2003
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (7) , 3112-8
- https://doi.org/10.1128/jcm.41.7.3112-3118.2003
Abstract
Cag pathogenicity island-containingHelicobacter pylori(type I) induces signal transduction pathways resulting in tyrosine phosphorylation of proteins adjacent to the site of bacterial adhesion on host gastric epithelial cells. Conventional block PCR-restriction fragment length polymorphism (RFLP) and real-time LightCycler (LC) PCR hybridization assays, validated by direct sequencing, were designed to test for the presence of three nucleotide sequences corresponding to tyrosine phosphorylation motifs (TPMs) A, B, and C in 84 isolates ofH. pyloritype I from patients in England. Overall, the PCR assays demonstrated that one or more TPMs were present in 62 strains (75%). Motif A was common (71% of strains), whereas motifs B and C were rarer (8% of strains). Strains lacking a TPM were typically vacuolating cytotoxin genotypevacAm2. Motif A was widely distributed in relation to disease severity and was more commonly (but not significantly [P= 0.071]) associated with gastric ulcer than with duodenal ulcer (86 versus 56%). The LC hybridization assay provided a rapid means of detecting all three motifs, but RFLP analysis was more specific for TPM-A. TPMs provide novel additional strain markers for definingcagAvariation, including identification of RFLP types within TPM-A. The presence of a particular TPM was not of direct diagnostic value, either singly or in combination, but the higher proportion of TPM-A strains in gastric ulcer patients merits further investigation.Keywords
This publication has 37 references indexed in Scilit:
- Helicobacter pylori CagA: Analysis of Sequence Diversity in Relation to Phosphorylation Motifs and Implications for the Role of CagA as a Virulence FactorHelicobacter, 2001
- PCR-Based Diagnosis of Helicobacter pylori Infection and Real-Time Determination of Clarithromycin Resistance Directly from Human Gastric Biopsy SamplesJournal of Clinical Microbiology, 2001
- Composition and Gene Expression of the cag Pathogenicity Island in Helicobacter pylori Strains Isolated from Gastric Carcinoma and Gastritis Patients in Costa RicaInfection and Immunity, 2001
- Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsiaJournal of Clinical Pathology, 2001
- Molecular epidemiology ofHelicobacter pyloriin England: prevalence ofcagpathogenicity island markers and IS605presence in relation to patient age and severity of gastric diseaseFEMS Immunology & Medical Microbiology, 2001
- Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV SecretionScience, 2000
- Is there significant variation in the risk of gastric cancer associated with Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1998
- H. pylori virulence factorsBritish Medical Bulletin, 1998
- Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.Journal of Clinical Pathology, 1996
- Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trialAlimentary Pharmacology & Therapeutics, 1995